Cellular regeneration strategies for macular degeneration: past, present and future

0
42


  • 1.

    Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013. Eye (Lond). 2016;30:602–7.

  • 2.

    Crump F. Society urgently calls for more funding into macular research. Macular Society. 2016. https://www.macularsociety.org/. Accessed 28 September 2016.

  • 3.

    Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96:752–6.

  • 4.

    Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728–38.

  • 5.

    Ambati J, Atkinson JP, Gelfand BD. Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438–51.

  • 6.

    Sears AE, Bernstein PS, Cideciyan AV, Hoyng C, Issa PC, Palczewski K, et al. Towards treatment of Stargardt disease: workshop organized and sponsored by the Foundation Fighting Blindness. Transl Vis Sci Technol. 2017;6:6.

  • 7.

    Farrar GJ, Millington-Ward S, Chadderton N, Mansergh FC, Palfi A. Gene therapies for inherited retinal disorders. Vis Neurosci. 2014;31:289–307.

  • 8.

    Mills JO, Jalil A, Stanga PE. Electronic retinal implants and artificial vision: journey and present. Eye. 2017;31:1383–98.

  • 9.

    Humayun MS, Weiland JD, Fujii GY, Greenberg R, Williamson R, Little J, et al. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res. 2003;43:2573–81.

  • 10.

    Cislo-Pakuluk A, Marycz K. A promising tool in retina regeneration: current perspectives and challenges when using mesenchymal progenitor stem cells in veterinary and human ophthalmological applications. Stem Cell Rev. 2017;13:598–602.

  • 11.

    Aharony I, Michowiz S, Goldenberg-Cohen N. The promise of stem cell-based therapeutics in ophthalmology. Neural Regen Res. 2017;12:173–80.

  • 12.

    Santos-Ferreira T, Llonch S, Borsch O, Postel K, Haas J, Ader M. Retinal transplantation of photoreceptors results in donor-host cytoplasmic exchange. Nat Commun. 2016;7:13028.

  • 13.

    Singh MS, Balmer J, Barnard AR, Aslam SA, Moralli D, Green CM, et al. Transplanted photoreceptor precursors transfer proteins to host photoreceptors by a mechanism of cytoplasmic fusion. Nat Commun. 2016;7:13537.

  • 14.

    Pearson RA, Barber AC, Rizzi M, Hippert C, Xue T, West EL, et al. Restoration of vision after transplantation of photoreceptors. Nature. 2012;485:99–103.

  • 15.

    Zarbin M. Cell-based therapy for degenerative retinal disease. Trends Mol Med. 2016;22:115–34.

  • 16.

    Klassen H. Stem cells in clinical trials for treatment of retinal degeneration. Expert Opin Biol Ther. 2016;16:7–14.

  • 17.

    Mellough CB, Collin J, Sernagor E, Wride NK, Steel DH, Lako M. Lab generated retina: realizing the dream. Vis Neurosci. 2014;31:317–32.

  • 18.

    Santos-Ferreira TF, Borsch O, Ader M. Rebuilding the missing part—a review on photoreceptor transplantation. Front Syst Neurosci. 2016;10:105.

  • 19.

    Pearson RA, Hippert C, Graca AB, Barber AC. Photoreceptor replacement therapy: challenges presented by the diseased recipient retinal environment. Vis Neurosci. 2014;31:333–44.

  • 20.

    MacLaren RE, Pearson RA. Stem cell therapy and the retina. Eye. 2007;21:1352–9.

  • 21.

    Jayakody SA, Gonzalez-Cordero A, Ali RR, Pearson RA. Cellular strategies for retinal repair by photoreceptor replacement. Prog Retin Eye Res. 2015;46:31–66.

  • 22.

    Alexander P, Thomson HA, Luff AJ, Lotery AJ. Retinal pigment epithelium transplantation: concepts, challenges, and future prospects. Eye. 2015;29:992–1002.

  • 23.

    Kolomeyer AM, Zarbin MA. Trophic factors in the pathogenesis and therapy for retinal degenerative diseases. Surv Ophthalmol. 2014;59:134–65.

  • 24.

    Lund RD, Adamson P, Sauve Y, Keegan DJ, Girman SV, Wang S, et al. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc Natl Acad Sci USA. 2001;98:9942–7.

  • 25.

    Chirco KR, Sohn EH, Stone EM, Tucker BA, Mullins RF. Structural and molecular changes in the aging choroid: implications for age-related macular degeneration. Eye. 2017;31:10–25.

  • 26.

    van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012;153:120. e122

  • 27.

    MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro PM, Milliken AB, et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology. 2007;114:561–70.

  • 28.

    Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC Jr., Desai U. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991;22:102–8.

  • 29.

    Wong D, Stanga P, Briggs M, Lenfestey P, Lancaster E, Li KK, et al. Case selection in macular relocation surgery for age related macular degeneration. Br J Ophthalmol. 2004;88:186–90.

  • 30.

    Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology. 2004;111:1715–24.

  • 31.

    Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol. 2002;134:560–5.

  • 32.

    Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237:313–25.

  • 33.

    Jones BW, Watt CB, Frederick JM, Baehr W, Chen CK, Levine EM, et al. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol. 2003;464:1–16.

  • 34.

    Seiler MJ, Aramant RB. Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res. 2012;31:661–87.

  • 35.

    del Cerro M, Notter MF, Grover DA, Olchowka J, Jiang LQ, Wiegand SJ, et al. Retinal transplants for cell replacement in phototoxic retinal degeneration. Prog Clin Biol Res. 1989;314:673–86.

  • 36.

    Gouras P, Du J, Gelanze M, Lopez R, Kwun R, Kjeldbye H, et al. Survival and synapse formation of transplanted rat rods. J Neural Transplant Plast. 1991;2:91–100.

  • 37.

    MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, et al. Retinal repair by transplantation of photoreceptor precursors. Nature. 2006;444:203–7.

  • 38.

    Bartsch U, Oriyakhel W, Kenna PF, Linke S, Richard G, Petrowitz B, et al. Retinal cells integrate into the outer nuclear layer and differentiate into mature photoreceptors after subretinal transplantation into adult mice. Exp Eye Res. 2008;86:691–700.

  • 39.

    Pearson RA, Gonzalez-Cordero A, West EL, Ribeiro JR, Aghaizu N, Goh D, et al. Donor and host photoreceptors engage in material transfer following transplantation of post-mitotic photoreceptor precursors. Nat Commun. 2016;7:13029.

  • 40.

    Pearson RA, Barber AC, West EL, MacLaren RE, Duran Y, Bainbridge JW, et al. Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant. 2010;19:487–503.

  • 41.

    Gust J, Reh TA. Adult donor rod photoreceptors integrate into the mature mouse retina. Invest Ophthalmol Vis Sci. 2011;52:5266–72.

  • 42.

    Santos-Ferreira T, Postel K, Stutzki H, Kurth T, Zeck G, Ader M. Daylight vision repair by cell transplantation. Stem Cells. 2015;33:79–90.

  • 43.

    Santos-Ferreira T, Volkner M, Borsch O, Haas J, Cimalla P, Vasudevan P, et al. Stem cell-derived photoreceptor transplants differentially integrate into mouse models of cone-rod dystrophy. Invest Ophthalmol Vis Sci. 2016;57:3509–20.

  • 44.

    Singh MS, Charbel Issa P, Butler R, Martin C, Lipinski DM, Sekaran S, et al. Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation. Proc Natl Acad Sci USA. 2013;110:1101–6.

  • 45.

    Klassen H, Lund RD. Retinal transplants can drive a pupillary reflex in host rat brains. Proc Natl Acad Sci USA. 1987;84:6958–60.

  • 46.

    Ashwell KW, Hollander H, Streit W, Stone J. The appearance and distribution of microglia in the developing retina of the rat. Vis Neurosci. 1989;2:437–48.

  • 47.

    Diaz-Araya CM, Provis JM, Penfold PL. Ontogeny and cellular expression of MHC and leucocyte antigens in human retina. Glia. 1995;15:458–70.

  • 48.

    Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1997;65:555–68.

  • 49.

    Gouras P, Du J, Kjeldbye H, Yamamoto S, Zack DJ. Reconstruction of degenerate rd mouse retina by transplantation of transgenic photoreceptors. Invest Ophthalmol Vis Sci. 1992;33:2579–86.

  • 50.

    Gouras P, Tanabe T. Survival and integration of neural retinal transplants in rd mice. Graefes Arch Clin Exp Ophthalmol. 2003;241:403–9.

  • 51.

    Sagdullaev BT, Aramant RB, Seiler MJ, Woch G, McCall MA. Retinal transplantation-induced recovery of retinotectal visual function in a rodent model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2003;44:1686–95.

  • 52.

    Seiler MJ, Aramant RB, Thomas BB, Peng Q, Sadda SR, Keirstead HS. Visual restoration and transplant connectivity in degenerate rats implanted with retinal progenitor sheets. Eur J Neurosci. 2010;31:508–20.

  • 53.

    Seiler MJ, Aramant RB. Intact sheets of fetal retina transplanted to restore damaged rat retinas. Invest Ophthalmol Vis Sci. 1998;39:2121–31.

  • 54.

    Silverman MS, Hughes SE. Transplantation of photoreceptors to light-damaged retina. Invest Ophthalmol Vis Sci. 1989;30:1684–90.

  • 55.

    Huang JC, Ishida M, Hersh P, Sugino IK, Zarbin MA. Preparation and transplantation of photoreceptor sheets. Curr Eye Res. 1998;17:573–85.

  • 56.

    Tezel TH, Kaplan HJ. Harvest and storage of adult human photoreceptor cells: the vibratome compared to the excimer laser. Curr Eye Res. 1998;17:748–56.

  • 57.

    Ghosh F, Juliusson B, Arner K, Ehinger B. Partial and full-thickness neuroretinal transplants. Exp Eye Res. 1999;68:67–74.

  • 58.

    Das T, del Cerro M, Jalali S, Rao VS, Gullapalli VK, Little C, et al. The transplantation of human fetal neuroretinal cells in advanced retinitis pigmentosa patients: results of a long-term safety study. Exp Neurol. 1999;157:58–68.

  • 59.

    Humayun MS, de Juan E Jr, del Cerro M, Dagnelie G, Radner W, Sadda SR, et al. Human neural retinal transplantation. Invest Ophthalmol Vis Sci. 2000;41:3100–6.

  • 60.

    Berger AS, Tezel TH, Del Priore LV, Kaplan HJ. Photoreceptor transplantation in retinitis pigmentosa: short-term follow-up. Ophthalmology. 2003;110:383–91.

  • 61.

    Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol. 2008;146:172–82.

  • 62.

    del Cerro M, Humayun MS, Sadda SR, Cao J, Hayashi N, Green WR, et al. Histologic correlation of human neural retinal transplantation. Invest Ophthalmol Vis Sci. 2000;41:3142–8.

  • 63.

    Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217–81.

  • 64.

    Buch PK, MacLaren RE, Ali RR. Neuroprotective gene therapy for the treatment of inherited retinal degeneration. Curr Gene Ther. 2007;7:434–45.

  • 65.

    Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52:2219–26.

  • 66.

    Zhang K, Hopkins JJ, Heier JS, Birch DG, Halperin LS, Albini TA, et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA. 2011;108:6241–5.

  • 67.

    Wen R, Tao W, Li Y, Sieving PA. CNTF and retina. Prog Retin Eye Res. 2012;31:136–51.

  • 68.

    Taylor S, Srinivasan B, Wordinger RJ, Roque RS. Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res. 2003;111:189–97.

  • 69.

    Di Polo A, Cheng L, Bray GM, Aguayo AJ. Colocalization of TrkB and brain-derived neurotrophic factor proteins in green-red-sensitive cone outer segments. Invest Ophthalmol Vis Sci. 2000;41:4014–21.

  • 70.

    Mohand-Said S, Hicks D, Dreyfus H, Sahel JA. Selective transplantation of rods delays cone loss in a retinitis pigmentosa model. Arch Ophthalmol. 2000;118:807–11.

  • 71.

    Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz AC, Clerin E, et al. Identification and characterization of rod-derived cone viability factor. Nat Genet. 2004;36:755–9.

  • 72.

    McGill TJ, Cottam B, Lu B, Wang S, Girman S, Tian C, et al. Transplantation of human central nervous system stem cells—neuroprotection in retinal degeneration. Eur J Neurosci. 2012;35:468–77.

  • 73.

    Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9–24.

  • 74.

    Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci USA. 2008;105:14638–43.

  • 75.

    Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts. Proc Natl Acad Sci USA. 1998;95:3908–13.

  • 76.

    Karl MO, Reh TA. Regenerative medicine for retinal diseases: activating endogenous repair mechanisms. Trends Mol Med. 2010;16:193–202.

  • 77.

    Bernardos RL, Barthel LK, Meyers JR, Raymond PA. Late-stage neuronal progenitors in the retina are radial Muller glia that function as retinal stem cells. J Neurosci. 2007;27:7028–40.

  • 78.

    Jayaram H, Jones MF, Eastlake K, Cottrill PB, Becker S, Wiseman J, et al. Transplantation of photoreceptors derived from human Muller glia restore rod function in the P23H rat. Stem Cells Transl Med. 2014;3:323–33.

  • 79.

    Ahmad I, Das AV, James J, Bhattacharya S, Zhao X. Neural stem cells in the mammalian eye: types and regulation. Semin Cell Dev Biol. 2004;15:53–62.

  • 80.

    Blenkinsop TA, Salero E, Stern JH, Temple S. The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye. Methods Mol Biol. 2013;945:45–65.

  • 81.

    Roesch K, Jadhav AP, Trimarchi JM, Stadler MB, Roska B, Sun BB, et al. The transcriptome of retinal Muller glial cells. J Comp Neurol. 2008;509:225–38.

  • 82.

    Giannelli SG, Demontis GC, Pertile G, Rama P, Broccoli V. Adult human Muller glia cells are a highly efficient source of rod photoreceptors. Stem Cells. 2011;29:344–56.

  • 83.

    Bhatia B, Singhal S, Lawrence JM, Khaw PT, Limb GA. Distribution of Muller stem cells within the neural retina: evidence for the existence of a ciliary margin-like zone in the adult human eye. Exp Eye Res. 2009;89:373–82.

  • 84.

    Jorstad NL, Wilken MS, Grimes WN, Wohl SG, VandenBosch LS, Yoshimatsu T, et al. Stimulation of functional neuronal regeneration from Muller glia in adult mice. Nature. 2017;548:103–7.

  • 85.

    Abe T, Yoshida M, Yoshioka Y, Wakusawa R, Tokita-Ishikawa Y, Seto H, et al. Iris pigment epithelial cell transplantation for degenerative retinal diseases. Prog Retin Eye Res. 2007;26:302–21.

  • 86.

    Crafoord S, Geng L, Seregard S, Algvere PV. Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space. Acta Ophthalmol Scand. 2002;80:387–94.

  • 87.

    Rezai KA, Kohen L, Wiedemann P, Heimann K. Iris pigment epithelium transplantation. Graefes Arch Clin Exp Ophthalmol. 1997;235:558–62.

  • 88.

    Thumann G, Kociok N, Bartz-Schmidt KU, Esser P, Schraermeyer U, Heimann K. Detection of mRNA for proteins involved in retinol metabolism in iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 1999;237:1046–51.

  • 89.

    Dintelmann TS, Heimann K, Kayatz P, Schraermeyer U. Comparative study of ROS degradation by IPE and RPE cells in vitro. Graefes Arch Clin Exp Ophthalmol. 1999;237:830–9.

  • 90.

    Kociok N, Heppekausen H, Schraermeyer U, Esser P, Thumann G, Grisanti S, et al. The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells. Exp Eye Res. 1998;67:237–50.

  • 91.

    Abe T, Yoshida M, Tomita H, Kano T, Sato M, Wada Y, et al. Auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration: short-term results. Tohoku J Exp Med. 2000;191:7–20.

  • 92.

    Thumann G, Aisenbrey S, Schraermeyer U, Lafaut B, Esser P, Walter P, et al. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol. 2000;118:1350–5.

  • 93.

    Aisenbrey S, Lafaut BA, Szurman P, Hilgers RD, Esser P, Walter P, et al. Iris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-up. Arch Ophthalmol. 2006;124:183–8.

  • 94.

    Salero E, Blenkinsop TA, Corneo B, Harris A, Rabin D, Stern JH, et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell. 2012;10:88–95.

  • 95.

    Davis RJ, Alam NM, Zhao C, Muller C, Saini JS, Blenkinsop TA, et al. The developmental stage of adult human stem cell-derived retinal pigment epithelium cells influences transplant efficacy for vision rescue. Stem Cell Rep. 2017;9:42–49.

  • 96.

    Klassen HJ, Ng TF, Kurimoto Y, Kirov I, Shatos M, Coffey P, et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci. 2004;45:4167–73.

  • 97.

    Cicero SA, Johnson D, Reyntjens S, Frase S, Connell S, Chow LM, et al. Cells previously identified as retinal stem cells are pigmented ciliary epithelial cells. Proc Natl Acad Sci USA. 2009;106:6685–90.

  • 98.

    Gualdoni S, Baron M, Lakowski J, Decembrini S, Smith AJ, Pearson RA, et al. Adult ciliary epithelial cells, previously identified as retinal stem cells with potential for retinal repair, fail to differentiate into new rod photoreceptors. Stem Cells. 2010;28:1048–59.

  • 99.

    Czekaj M, Haas J, Gebhardt M, Muller-Reichert T, Humphries P, Farrar J, et al. In vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes. PLoS ONE. 2012;7:e41798.

  • 100.

    Sakaguchi DS, Van Hoffelen SJ, Young MJ. Differentiation and morphological integration of neural progenitor cells transplanted into the developing mammalian eye. Ann N Y Acad Sci. 2003;995:127–39.

  • 101.

    Klassen H, Kiilgaard JF, Warfvinge K, Samuel MS, Prather RS, Wong F, et al. Photoreceptor differentiation following transplantation of allogeneic retinal progenitor cells to the dystrophic Rhodopsin Pro347Leu transgenic pig. Stem Cells Int. 2012;2012:939801.

  • 102.

    Abud M, Baranov P, Hicks C, Patel S, Lieppman B, Regatieri C, et al. The effect of transient local anti-inflammatory treatment on the survival of pig retinal progenitor cell allotransplants. Transl Vis Sci Technol. 2015;4:6.

  • 103.

    Semo M, Haamedi N, Stevanato L, Carter D, Brooke G, Young M, et al. Efficacy and safety of human retinal progenitor cells. Transl Vis Sci Technol. 2016;5:6.

  • 104.

    Redenti S, Neeley WL, Rompani S, Saigal S, Yang J, Klassen H, et al. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials. 2009;30:3405–14.

  • 105.

    Ballios BG, Cooke MJ, Donaldson L, Coles BL, Morshead CM, van der Kooy D, et al. A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation. Stem Cell Rep. 2015;4:1031–45.

  • 106.

    Borooah S, Phillips MJ, Bilican B, Wright AF, Wilmut I, Chandran S, et al. Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res. 2013;37:163–81.

  • 107.

    Mellough CB, Steel DH, Lako M. Genetic basis of inherited macular dystrophies and implications for stem cell therapy. Stem Cells. 2009;27:2833–45.

  • 108.

    Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.

  • 109.

    Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72.

  • 110.

    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.

  • 111.

    Lako M, Armstrong L, Stojkovic M. Induced pluripotent stem cells: it looks simple but can looks deceive? Stem Cells. 2010;28:845–50.

  • 112.

    Chichagova V, Hallam D, Collin J, Buskin A, Saretzki G, Armstrong L, et al. Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m.3243A>G mitochondrial DNA mutation. Sci Rep. 2017;7:12320.

  • 113.

    Hallam D, Collin J, Bojic S, Chichagova V, Buskin A, Xu Y, et al. An induced pluripotent stem cell patient specific model of complement factor H (Y402H) polymorphism displays characteristic features of age-related macular degeneration and indicates a beneficial role for UV light exposure. Stem Cells. 2017;35:2305–20.

  • 114.

    Collin J, Lako M. Concise review: putting a finger on stem cell biology: zinc finger nuclease-driven targeted genetic editing in human pluripotent stem cells. Stem Cells. 2011;29:1021–33.

  • 115.

    Burnight ER, Gupta M, Wiley LA, Anfinson KR, Tran A, Triboulet R, et al. Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration. Mol Ther. 2017;25:1999–2013.

  • 116.

    Ovando-Roche P, Georgiadis A, Smith AJ, Pearson RA, Ali RR. Harnessing the potential of human pluripotent stem cells and gene editing for the treatment of retinal degeneration. Curr Stem Cell Rep. 2017;3:112–23.

  • 117.

    Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci. 2004;45:4251–5.

  • 118.

    Chichagova V, Sanchez-Vera I, Armstrong L, Steel D, Lako M. Methods in molecular biology. Ch. 205. Humana Press; New York, 2015. p. 1–23.

  • 119.

    Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385:509–16.

  • 120.

    Mandai M, Kurimoto Y, Takahashi M. Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med. 2017;377:792–3.

  • 121.

    Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385:810–3.

  • 122.

    Wolf DP, Morey R, Kang E, Ma H, Hayama T, Laurent LC, et al. Concise review: embryonic stem cells derived by somatic cell nuclear transfer: a horse in the race? Stem Cells. 2017;35:26–34.

  • 123.

    Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103:12769–74.

  • 124.

    Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA. 2009;106:16698–703.

  • 125.

    Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol. 2008;26:215–24.

  • 126.

    Rowland TJ, Buchholz DE, Clegg DO. Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol. 2012;227:457–66.

  • 127.

    Mellough CB, Sernagor E, Moreno-Gimeno I, Steel DH, Lako M. Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells. 2012;30:673–86.

  • 128.

    Mellough CB, Collin J, Khazim M, White K, Sernagor E, Steel DH, et al. IGF-1 signaling plays an important role in the formation of three-dimensional laminated neural retina and other ocular structures from human embryonic stem cells. Stem Cells. 2015;33:2416–30.

  • 129.

    Munoz-Sanjuan I, Brivanlou AH. Neural induction, the default model and embryonic stem cells. Nat Rev Neurosci. 2002;3:271–80.

  • 130.

    Osakada F, Jin ZB, Hirami Y, Ikeda H, Danjyo T, Watanabe K, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci. 2009;122:3169–79.

  • 131.

    Meyer JS, Howden SE, Wallace KA, Verhoeven AD, Wright LS, Capowski EE, et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells. 2011;29:1206–18.

  • 132.

    Zhu Y, Carido M, Meinhardt A, Kurth T, Karl MO, Ader M, et al. Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PLoS ONE. 2013;8:e54552.

  • 133.

    Plaza Reyes A, Petrus-Reurer S, Antonsson L, Stenfelt S, Bartuma H, Panula S, et al. Xeno-free and defined human embryonic stem cell-derived retinal pigment epithelial cells functionally integrate in a large-eyed preclinical model. Stem Cell Rep. 2016;6:9–17.

  • 134.

    Sorkio A, Hongisto H, Kaarniranta K, Uusitalo H, Juuti-Uusitalo K, Skottman H. Structure and barrier properties of human embryonic stem cell-derived retinal pigment epithelial cells are affected by extracellular matrix protein coating. Tissue Eng Part A. 2014;20:622–34.

  • 135.

    Stacpoole SR, Bilican B, Webber DJ, Luzhynskaya A, He XL, Compston A, et al. Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation. Cell Death Differ. 2011;18:1016–23.

  • 136.

    Bae D, Mondragon-Teran P, Hernandez D, Ruban L, Mason C, Bhattacharya SS, et al. Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. Stem Cells Dev. 2012;21:1344–55.

  • 137.

    Garita-Hernandez M, Diaz-Corrales F, Lukovic D, Gonzalez-Guede I, Diez-Lloret A, Valdes-Sanchez ML, et al. Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro. Stem Cells. 2013;31:966–78.

  • 138.

    Miyagishima KJ, Wan Q, Corneo B, Sharma R, Lotfi MR, Boles NC, et al. In pursuit of authenticity: induced pluripotent stem cell-derived retinal pigment epithelium for clinical applications. Stem Cells Transl Med. 2016;5:1562–74.

  • 139.

    Li P, Sun X, Ma Z, Liu Y, Jin Y, Ge R, et al. Transcriptional reactivation of OTX2, RX1 and SIX3 during reprogramming contributes to the generation of RPE cells from human iPSCs. Int J Biol Sci. 2016;12:505–17.

  • 140.

    Perales-Clemente E, Cook AN, Evans JM, Roellinger S, Secreto F, Emmanuele V, et al. Natural underlying mtDNA heteroplasmy as a potential source of intra-person hiPSC variability. EMBO J. 2016;35:1979–90.

  • 141.

    Ortmann D, Vallier L. Variability of human pluripotent stem cell lines. Curr Opin Genet Dev. 2017;46:179–85.

  • 142.

    Xiao J, Mai DH, Xie L. Resetting human naive pluripotency. Genet Epigenet. 2016;8:37–41.

  • 143.

    Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472:51–56.

  • 144.

    Phillips MJ, Wallace KA, Dickerson SJ, Miller MJ, Verhoeven AD, Martin JM, et al. Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci. 2012;53:2007–19.

  • 145.

    Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K, et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell. 2012;10:771–85.

  • 146.

    Zhong X, Gutierrez C, Xue T, Hampton C, Vergara MN, Cao LH, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014;5:4047.

  • 147.

    Gonzalez-Cordero A, Kruczek K, Naeem A, Fernando M, Kloc M, Ribeiro J, et al. Recapitulation of human retinal development from human pluripotent stem cells generates transplantable populations of cone photoreceptors. Stem Cell Rep. 2017;9:820–37.

  • 148.

    Bharti K, Miller SS, Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011;24:21–34.

  • 149.

    Collin J, Mellough CB, Dorgau B, Przyborski S, Moreno-Gimeno I, Lako M. Using zinc finger nuclease technology to generate crx-reporter human embryonic stem cells as a tool to identify and study the emergence of photoreceptors precursors during pluripotent stem cell differentiation. Stem Cells. 2016;34:311–21.

  • 150.

    Koso H, Minami C, Tabata Y, Inoue M, Sasaki E, Satoh S, et al. CD73, a novel cell surface antigen that characterizes retinal photoreceptor precursor cells. Invest Ophthalmol Vis Sci. 2009;50:5411–8.

  • 151.

    Lakowski J, Gonzalez-Cordero A, West EL, Han YT, Welby E, Naeem A. et al. Transplantation of photoreceptor precursors isolated via a cell surface biomarker panel from embryonic stem cell-derived self-forming retina. Stem Cells. 2015;33:2469–82.

  • 152.

    Lakowski J, Han YT, Pearson RA, Gonzalez-Cordero A, West EL, Gualdoni S, et al. Effective transplantation of photoreceptor precursor cells selected via cell surface antigen expression. Stem Cells. 2011;29:1391–404.

  • 153.

    Eberle D, Schubert S, Postel K, Corbeil D, Ader M. Increased integration of transplanted CD73-positive photoreceptor precursors into adult mouse retina. Invest Ophthalmol Vis Sci. 2011;52:6462–71.

  • 154.

    Welby E, Lakowski J, Di Foggia V, Budinger D, Gonzalez-Cordero A, Lun ATL. et al. Isolation and comparative transcriptome analysis of human fetal and iPSC-derived cone photoreceptor cells. Stem Cell Rep. 2017;9:1898–915.

  • 155.

    Carido M, Zhu Y, Postel K, Benkner B, Cimalla P, Karl MO, et al. Characterization of a mouse model with complete RPE loss and its use for RPE cell transplantation. Invest Ophthalmol Vis Sci. 2014;55:5431–44.

  • 156.

    Keenan TD, Pickford CE, Holley RJ, Clark SJ, Lin W, Dowsey AW, et al. Age-dependent changes in heparan sulfate in human Bruch’s membrane: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:5370–9.

  • 157.

    Sugino IK, Sun Q, Cheewatrakoolpong N, Malcuit C, Zarbin MA. Biochemical restoration of aged human Bruch’s membrane: experimental studies to improve retinal pigment epithelium transplant survival and differentiation. Dev Ophthalmol. 2014;53:133–42.

  • 158.

    Afshari FT, Kwok JC, Andrews MR, Blits B, Martin KR, Faissner A, et al. Integrin activation or alpha 9 expression allows retinal pigmented epithelial cell adhesion on Bruch’s membrane in wet age-related macular degeneration. Brain. 2010;133:448–64.

  • 159.

    Tezel TH, Del Priore LV. Repopulation of different layers of host human Bruch’s membrane by retinal pigment epithelial cell grafts. Invest Ophthalmol Vis Sci. 1999;40:767–74.

  • 160.

    Tezel TH, Del Priore LV, Kaplan HJ. Reengineering of aged Bruch’s membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci. 2004;45:3337–48.

  • 161.

    Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch’s membrane. Invest Ophthalmol Vis Sci. 1999;40:467–76.

  • 162.

    Gullapalli VK, Sugino IK, Zarbin MA. Culture-induced increase in alpha integrin subunit expression in retinal pigment epithelium is important for improved resurfacing of aged human Bruch’s membrane. Exp Eye Res. 2008;86:189–200.

  • 163.

    Sugino IK, Rapista A, Sun Q, Wang J, Nunes CF, Cheewatrakoolpong N, et al. A method to enhance cell survival on Bruch’s membrane in eyes affected by age and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:9598–609.

  • 164.

    Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598–614.

  • 165.

    Hynes SR, Lavik EB. A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol. 2010;248:763–78.

  • 166.

    Delplace V, Payne S, Shoichet M. Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions. J Control Release. 2015;219:652–68.

  • 167.

    Carr AJ, Smart MJ, Ramsden CM, Powner MB, da Cruz L, Coffey PJ. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 2013;36:385–95.

  • 168.

    Lu B, Zhu D, Hinton D, Humayun MS, Tai YC. Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells. Biomed Micro. 2012;14:659–67.

  • 169.

    Xiang P, Wu KC, Zhu Y, Xiang L, Li C, Chen DL, et al. A novel Bruch’s membrane-mimetic electrospun substrate scaffold for human retinal pigment epithelium cells. Biomaterials. 2014;35:9777–88.

  • 170.

    Thieltges F, Stanzel BV, Liu Z, Holz FG. A nanofibrillar surface promotes superior growth characteristics in cultured human retinal pigment epithelium. Ophthalmic Res. 2011;46:133–40.

  • 171.

    Shadforth AM, George KA, Kwan AS, Chirila TV, Harkin DG. The cultivation of human retinal pigment epithelial cells on Bombyx mori silk fibroin. Biomaterials. 2012;33:4110–7.

  • 172.

    Treharne AJ, Thomson HA, Grossel MC, Lotery AJ. Developing methacrylate-based copolymers as an artificial Bruch’s membrane substitute. J Biomed Mater Res A. 2012;100:2358–64.

  • 173.

    Warnke PH, Alamein M, Skabo S, Stephens S, Bourke R, Heiner P, et al. Primordium of an artificial Bruch’s membrane made of nanofibers for engineering of retinal pigment epithelium cell monolayers. Acta Biomater. 2013;9:9414–22.

  • 174.

    Liu Z, Yu N, Holz FG, Yang F, Stanzel BV. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837–50.

  • 175.

    Garber K. RIKEN suspends first clinical trial involving induced pluripotent stem cells. Nat Biotechnol. 2015;33:890–1.

  • 176.

    Cereda MG, Parolini B, Bellesini E, Pertile G. Surgery for CNV and autologous choroidal RPE patch transplantation: exposing the submacular space. Graefes Arch Clin Exp Ophthalmol. 2010;248:37–47.

  • 177.

    Veckeneer M, Augustinus C, Feron E, Schauwvlieghe PP, Ruys J, Cosemans I, et al. OCT angiography documented reperfusion of translocated autologous full thickness RPE-choroid graft for complicated neovascular age-related macular degeneration. Eye. 2017;31:1274–83.

  • 178.

    Yang Y, Mohand-Said S, Danan A, Simonutti M, Fontaine V, Clerin E, et al. Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol Ther. 2009;17:787–95.

  • 179.

    Yang Y, Mohand-Said S, Leveillard T, Fontaine V, Simonutti M, Sahel JA. Transplantation of photoreceptor and total neural retina preserves cone function in P23H rhodopsin transgenic rat. PLoS ONE. 2010;5:e13469.

  • 180.

    Suzuki T, Akimoto M, Imai H, Ueda Y, Mandai M, Yoshimura N, et al. Chondroitinase ABC treatment enhances synaptogenesis between transplant and host neurons in model of retinal degeneration. Cell Transplant. 2007;16:493–503.

  • 181.

    Yao J, Tucker BA, Zhang X, Checa-Casalengua P, Herrero-Vanrell R, Young MJ. Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells. Biomaterials. 2011;32:1041–50.

  • 182.

    Barber AC, Hippert C, Duran Y, West EL, Bainbridge JW, Warre-Cornish K, et al. Repair of the degenerate retina by photoreceptor transplantation. Proc Natl Acad Sci USA. 2013;110:354–9.

  • 183.

    Yao J, Feathers KL, Khanna H, Thompson D, Tsilfidis C, Hauswirth WW, et al. XIAP therapy increases survival of transplanted rod precursors in a degenerating host retina. Invest Ophthalmol Vis Sci. 2011;52:1567–72.

  • 184.

    West EL, Pearson RA, Barker SE, Luhmann UF, Maclaren RE, Barber AC, et al. Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells. 2010;28:1997–2007.

  • 185.

    Eberle D, Kurth T, Santos-Ferreira T, Wilson J, Corbeil D, Ader M. Outer segment formation of transplanted photoreceptor precursor cells. PLoS ONE. 2012;7:e46305.

  • 186.

    Peachey NS, Ball SL. Electrophysiological analysis of visual function in mutant mice. Doc Ophthalmol. 2003;107:13–36.

  • 187.

    Cuenca N, Pinilla I, Sauve Y, Lu B, Wang S, Lund RD. Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience. 2004;127:301–17.

  • 188.

    Grewal DS, Mahmoud TH. Autologous Neurosensory Retinal Free Flap for Closure of Refractory Myopic Macular Holes. JAMA Ophthalmol. 2016;134:229–30.

  • 189.

    jCyte. jCyte seeing the future through science. http://jcyte.com/jcell-therapy (accessed 17 November 2017).

  • 190.

    Mandai M, Fujii M, Hashiguchi T, Sunagawa GA, Ito SI, Sun J, et al. iPSC-derived retina transplants improve vision in rd1 end-stage retinal-degeneration mice. Stem Cell Rep. 2017;8:1112–3.

  • 191.

    Shirai H, Mandai M, Matsushita K, Kuwahara A, Yonemura S, Nakano T, et al. Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration. Proc Natl Acad Sci USA. 2016;113:E81–90.

  • 192.

    Zhou S, Flamier A, Abdouh M, Tetreault N, Barabino A, Wadhwa S, et al. Differentiation of human embryonic stem cells into cone photoreceptors through simultaneous inhibition of BMP, TGFbeta and Wnt signaling. Development. 2015;142:3294–306.

  • 193.

    Hunt NC, Hallam D, Karimi A, Mellough CB, Chen J, Steel DH, et al. 3D culture of human pluripotent stem cells in RGD-alginate hydrogel improves retinal tissue development. Acta Biomater. 2017;49:329–43.

  • 194.

    Lorber B, Hsiao WK, Martin KR. Three-dimensional printing of the retina. Curr Opin Ophthalmol. 2016;27:262–7.

  • 195.

    Hamilton RD, Foss AJ, Leach L. Establishment of a human in vitro model of the outer blood-retinal barrier. J Anat. 2007;211:707–16.

  • 196.

    Songstad AE, Wiley LA, Duong K, Kaalberg E, Flamme-Wiese MJ, Cranston CM, et al. Generating iPSC-derived choroidal endothelial cells to study age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56:8258–67.

  • 197.

    Songstad AE, Worthington KS, Chirco KR, Giacalone JC, Whitmore SS, Anfinson KR. et al. Connective tissue growth factor promotes efficient generation of human induced pluripotent stem cell-derived choroidal endothelium. Stem Cells Transl Med. 2017;6:1533–46.

  • 198.

    Algvere PV, Gouras P, Dafgard Kopp E. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol. 1999;9:217–30.

  • 199.

    Sugita S, Iwasaki Y, Makabe K, Kamao H, Mandai M, Shiina T, et al. Successful transplantation of retinal pigment epithelial cells from MHC homozygote iPSCs in MHC-matched models. Stem Cell Rep. 2016;7:635–48.

  • 200.

    Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474:212–5.

  • 201.

    Siqueira RC, Messias A, Messias K, Arcieri RS, Ruiz MA, Souza NF, et al. Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial). Stem Cell Res Ther. 2015;6:29.

  • 202.

    ClinicalTrials.gov. Clinical trial of autologous intravitreal bone marrow CD34+stem cells for retinopathy. 2015. https://clinicaltrials.gov/ct2/show/NCT01736059?term=stem+cell+retinitis+pigmentosa&rank=7 (accessed 17 November 2017).

  • 203.

    Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, et al. Intravitreal autologous bone marrow CD34+cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014;56:81–89.

  • 204.

    Cao J, Murat C, An W, Yao X, Lee J, Santulli-Marotto S, et al. Human umbilical tissue-derived cells rescue retinal pigment epithelium dysfunction in retinal degeneration. Stem Cells. 2016;34:367–79.

  • 205.

    Koh S, Kim N, Yin HH, Harris IR, Dejneka NS, Eroglu C. Human umbilical tissue-derived cells promote synapse formation and neurite outgrowth via thrombospondin family proteins. J Neurosci. 2015;35:15649–65.

  • 206.

    Gamm DM, Wang S, Lu B, Girman S, Holmes T, Bischoff N, et al. Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS ONE. 2007;2:e338.

  • 207.

    Wang S, Girman S, Lu B, Bischoff N, Holmes T, Shearer R, et al. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2008;49:3201–6.

  • 208.

    Cuenca N, Fernandez-Sanchez L, McGill TJ, Lu B, Wang S, Lund R, et al. Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Invest Ophthalmol Vis Sci. 2013;54:6745–56.

  • 209.

    Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE 2nd, et al. Vision loss after intravitreal injection of autologous “stem cells” for AMD. N Engl J Med. 2017;376:1047–53.

  • 210.

    Bissell AJ, Yalcinbayir O, Akduman L. Bilateral geographic atrophy: spontaneous visual improvement after loss of vision in the fellow eye. Acta Ophthalmol Scand. 2005;83:514–5.

  • 211.

    Sunness JS. Stem cells in age-related macular degeneration and Stargardt’s macular dystrophy. Lancet. 2015;386:29.

  • 212.

    Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385:509–16.

  • 213.

    Song WK, Park KM, Kim HJ, Lee JH, Choi J, Chong SY et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in asian patients. Stem Cell Rep. 2015:4;860–72.

  • 214.

    Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol. 201;156:3–292.

  • 215.

    Cotrim CC, Toscano L, Messias A, Jorge R, Siqueira RC. Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular 10.1038/s41433-018-0061-z degeneration. Clin Ophthalmol. 2017; 11:931–8.



  • Source link

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here